# Tyler Technologies Inc: financial statements, quarterly

TYL · NYSE · CIK 860731 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tyl.md) · [Financials](/companies/tyl/financials.md) · [Filings](/companies/tyl/filings.md) · [Insiders](/companies/tyl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tyl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [495](/filings/0000860731-24-000052.md) | [481 d](/filings/0000860731-26-000016.md) | [512](/filings/0000860731-25-000027.md) | [541](/filings/0000860731-25-000036.md) | [543](/filings/0000860731-25-000046.md) | [541 d](/filings/0000860731-26-000016.md) | [565](/filings/0000860731-26-000032.md) | [596](/filings/0000860731-26-000050.md) | [596](/filings/0000860731-25-000046.md) | [575 d](/filings/0000860731-26-000016.md) | [614](/filings/0000860731-26-000032.md) | [645](/filings/0000860731-26-000050.md) |
| Cost of revenue | $m | [270](/filings/0000860731-24-000052.md) | [268 d](/filings/0000860731-26-000016.md) | [289](/filings/0000860731-25-000027.md) | [303](/filings/0000860731-25-000036.md) | [306](/filings/0000860731-25-000046.md) | [304 d](/filings/0000860731-26-000016.md) | [298](/filings/0000860731-26-000032.md) | [323](/filings/0000860731-26-000050.md) | [314](/filings/0000860731-25-000046.md) | [313 d](/filings/0000860731-26-000016.md) | [317](/filings/0000860731-26-000032.md) | [338](/filings/0000860731-26-000050.md) |
| Gross profit | $m | [225](/filings/0000860731-24-000052.md) | [213 d](/filings/0000860731-26-000016.md) | [224](/filings/0000860731-25-000027.md) | [238](/filings/0000860731-25-000036.md) | [237](/filings/0000860731-25-000046.md) | [237 d](/filings/0000860731-26-000016.md) | [267](/filings/0000860731-26-000032.md) | [273](/filings/0000860731-26-000050.md) | [281](/filings/0000860731-25-000046.md) | [262 d](/filings/0000860731-26-000016.md) | [296](/filings/0000860731-26-000032.md) | [307](/filings/0000860731-26-000050.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [63.9](/filings/0000860731-24-000052.md) | [47.7 d](/filings/0000860731-26-000016.md) | [67.0](/filings/0000860731-25-000027.md) | [78.0](/filings/0000860731-25-000036.md) | [82.8](/filings/0000860731-25-000046.md) | [71.7 d](/filings/0000860731-26-000016.md) | [89.2](/filings/0000860731-26-000032.md) | [95.6](/filings/0000860731-26-000050.md) | [97.9](/filings/0000860731-25-000046.md) | [75.0 d](/filings/0000860731-26-000016.md) | [99.8](/filings/0000860731-26-000032.md) | [95.1](/filings/0000860731-26-000050.md) |
| Interest expense | $m | [5.8](/filings/0000860731-24-000052.md) | [3.8 d](/filings/0000860731-26-000016.md) | [2.2](/filings/0000860731-25-000027.md) | [1.3](/filings/0000860731-25-000036.md) | [1.2](/filings/0000860731-25-000046.md) | [1.3 d](/filings/0000860731-26-000016.md) | [1.2](/filings/0000860731-26-000032.md) | [1.3](/filings/0000860731-26-000050.md) | [1.2](/filings/0000860731-25-000046.md) | [1.3 d](/filings/0000860731-26-000016.md) | [1.1](/filings/0000860731-26-000032.md) | [3.0](/filings/0000860731-26-000050.md) |
| Income tax | $m | [11.9](/filings/0000860731-24-000052.md) | [5.7 d](/filings/0000860731-26-000016.md) | [12.5](/filings/0000860731-25-000027.md) | [10.9](/filings/0000860731-25-000036.md) | [10.2](/filings/0000860731-25-000046.md) | [11.5 d](/filings/0000860731-26-000016.md) | [14.2](/filings/0000860731-26-000032.md) | [17.9](/filings/0000860731-26-000050.md) | [23.2](/filings/0000860731-25-000046.md) | [19.4 d](/filings/0000860731-26-000016.md) | [25.2](/filings/0000860731-26-000032.md) | [27.1](/filings/0000860731-26-000050.md) |
| Net income | $m | [47.0](/filings/0000860731-24-000052.md) | [38.9 d](/filings/0000860731-26-000016.md) | [54.2](/filings/0000860731-25-000027.md) | [67.7](/filings/0000860731-25-000036.md) | [75.9](/filings/0000860731-25-000046.md) | [65.2 d](/filings/0000860731-26-000016.md) | [81.1](/filings/0000860731-26-000032.md) | [84.6](/filings/0000860731-26-000050.md) | [84.4](/filings/0000860731-25-000046.md) | [65.5 d](/filings/0000860731-26-000016.md) | [81.2](/filings/0000860731-26-000032.md) | [93.5](/filings/0000860731-26-000050.md) |
| Diluted EPS | $ per share | [1.10](/filings/0000860731-24-000052.md) | not reported | [1.26](/filings/0000860731-25-000027.md) | [1.57](/filings/0000860731-25-000036.md) | [1.74](/filings/0000860731-25-000046.md) | not reported | [1.84](/filings/0000860731-26-000032.md) | [1.93](/filings/0000860731-26-000050.md) | [1.93](/filings/0000860731-25-000046.md) | not reported | [1.88](/filings/0000860731-26-000032.md) | [2.23](/filings/0000860731-26-000050.md) |
| Basic EPS | $ per share | [1.12](/filings/0000860731-24-000052.md) | not reported | [1.28](/filings/0000860731-25-000027.md) | [1.59](/filings/0000860731-25-000036.md) | [1.78](/filings/0000860731-25-000046.md) | not reported | [1.88](/filings/0000860731-26-000032.md) | [1.96](/filings/0000860731-26-000050.md) | [1.96](/filings/0000860731-25-000046.md) | not reported | [1.90](/filings/0000860731-26-000032.md) | [2.25](/filings/0000860731-26-000050.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [131](/filings/0000860731-23-000037.md) | [165](/filings/0000860731-25-000007.md) | [188](/filings/0000860731-24-000025.md) | [251](/filings/0000860731-24-000042.md) | [538](/filings/0000860731-24-000052.md) | [745](/filings/0000860731-26-000016.md) | [706](/filings/0000860731-25-000027.md) | [787](/filings/0000860731-25-000036.md) | [834](/filings/0000860731-25-000046.md) | [1,015](/filings/0000860731-26-000050.md) | [316](/filings/0000860731-26-000032.md) | [895](/filings/0000860731-26-000050.md) |
| Current assets | $m | [842](/filings/0000860731-23-000037.md) | [861](/filings/0000860731-25-000007.md) | [824](/filings/0000860731-24-000025.md) | [1,042](/filings/0000860731-24-000042.md) | [1,239](/filings/0000860731-24-000052.md) | [1,441](/filings/0000860731-26-000016.md) | [1,467](/filings/0000860731-25-000027.md) | [1,724](/filings/0000860731-25-000036.md) | [1,738](/filings/0000860731-25-000046.md) | [1,844](/filings/0000860731-26-000050.md) | [1,041](/filings/0000860731-26-000032.md) | [1,817](/filings/0000860731-26-000050.md) |
| Total assets | $m | [4,637](/filings/0000860731-23-000037.md) | [4,677](/filings/0000860731-25-000007.md) | [4,609](/filings/0000860731-24-000025.md) | [4,819](/filings/0000860731-24-000042.md) | [4,997](/filings/0000860731-24-000052.md) | [5,180](/filings/0000860731-26-000016.md) | [5,192](/filings/0000860731-25-000027.md) | [5,426](/filings/0000860731-25-000036.md) | [5,457](/filings/0000860731-25-000046.md) | [5,639](/filings/0000860731-26-000050.md) | [4,799](/filings/0000860731-26-000032.md) | [5,814](/filings/0000860731-26-000050.md) |
| Current liabilities | $m | [909](/filings/0000860731-23-000037.md) | [1,001](/filings/0000860731-25-000007.md) | [873](/filings/0000860731-24-000025.md) | [987](/filings/0000860731-24-000042.md) | [1,022](/filings/0000860731-24-000052.md) | [1,066](/filings/0000860731-26-000016.md) | [1,561](/filings/0000860731-25-000027.md) | [1,672](/filings/0000860731-25-000036.md) | [1,691](/filings/0000860731-25-000046.md) | [1,755](/filings/0000860731-26-000050.md) | [1,040](/filings/0000860731-26-000032.md) | [1,170](/filings/0000860731-26-000050.md) |
| Total liabilities | $m | [1,785](/filings/0000860731-23-000037.md) | [1,739](/filings/0000860731-25-000007.md) | [1,586](/filings/0000860731-24-000025.md) | [1,687](/filings/0000860731-24-000042.md) | [1,721](/filings/0000860731-24-000052.md) | [1,792](/filings/0000860731-26-000016.md) | [1,679](/filings/0000860731-25-000027.md) | [1,791](/filings/0000860731-25-000036.md) | [1,855](/filings/0000860731-25-000046.md) | [1,936](/filings/0000860731-26-000050.md) | [1,240](/filings/0000860731-26-000032.md) | [2,776](/filings/0000860731-26-000050.md) |
| Long-term debt | $m | [705](/filings/0000860731-23-000037.md) | [596](/filings/0000860731-25-000007.md) | [597](/filings/0000860731-24-000025.md) | [597](/filings/0000860731-24-000042.md) | [598](/filings/0000860731-24-000052.md) | [598](/filings/0000860731-25-000007.md) | [598](/filings/0000860731-25-000027.md) | [599](/filings/0000860731-25-000036.md) | [599](/filings/0000860731-25-000046.md) | [600](/filings/0000860731-26-000016.md) | not reported | not reported |
| Current portion of debt | $m | [30.0](/filings/0000860731-23-000037.md) | [49.8](/filings/0000860731-25-000007.md) | [0.0](/filings/0000860731-24-000025.md) | [0.0](/filings/0000860731-24-000042.md) | [0.0](/filings/0000860731-24-000052.md) | [0.0](/filings/0000860731-25-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,853](/filings/0000860731-24-000052.md) | [2,938](/filings/0000860731-26-000016.md) | [3,023](/filings/0000860731-25-000036.md) | [3,132](/filings/0000860731-25-000046.md) | [3,275](/filings/0000860731-25-000046.md) | [3,388](/filings/0000860731-26-000050.md) | [3,513](/filings/0000860731-26-000050.md) | [3,635](/filings/0000860731-26-000050.md) | [3,603](/filings/0000860731-25-000046.md) | [3,703](/filings/0000860731-26-000050.md) | [3,558](/filings/0000860731-26-000050.md) | [3,037](/filings/0000860731-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [177 d](/filings/0000860731-24-000052.md) | [147 d](/filings/0000860731-26-000016.md) | [71.8](/filings/0000860731-25-000027.md) | [64.3 d](/filings/0000860731-25-000036.md) | [264 d](/filings/0000860731-25-000046.md) | [225 d](/filings/0000860731-26-000016.md) | [56.2](/filings/0000860731-26-000032.md) | [98.3 d](/filings/0000860731-26-000050.md) | [255 d](/filings/0000860731-25-000046.md) | [244 d](/filings/0000860731-26-000016.md) | [107](/filings/0000860731-26-000032.md) | [124 d](/filings/0000860731-26-000050.md) |
| Capital expenditure | $m | [6.1 d](/filings/0000860731-24-000052.md) | [8.0 d](/filings/0000860731-26-000016.md) | [7.3](/filings/0000860731-25-000027.md) | [6.6 d](/filings/0000860731-25-000036.md) | [2.9 d](/filings/0000860731-25-000046.md) | [3.8 d](/filings/0000860731-26-000016.md) | [2.3](/filings/0000860731-26-000032.md) | [5.5 d](/filings/0000860731-26-000050.md) | [3.9 d](/filings/0000860731-25-000046.md) | [4.3 d](/filings/0000860731-26-000016.md) | [3.2](/filings/0000860731-26-000032.md) | [5.1 d](/filings/0000860731-26-000050.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0000860731-25-000046.md) | [0.0 d](/filings/0000860731-26-000016.md) | [0.0](/filings/0000860731-26-000032.md) | [1.6 d](/filings/0000860731-26-000050.md) | [173 d](/filings/0000860731-25-000046.md) | [0.0 d](/filings/0000860731-26-000016.md) | [250](/filings/0000860731-26-000032.md) | [505 d](/filings/0000860731-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [42.4](/filings/0000860731-23-000037.md) | [42.5](/filings/0000860731-24-000025.md) | [42.8](/filings/0000860731-24-000042.md) | [42.8](/filings/0000860731-24-000052.md) | [43.1](/filings/0000860731-25-000027.md) | [43.3](/filings/0000860731-25-000036.md) | [43.7](/filings/0000860731-25-000046.md) | [43.9](/filings/0000860731-26-000032.md) | [43.9](/filings/0000860731-26-000050.md) | [43.8](/filings/0000860731-25-000046.md) | [43.1](/filings/0000860731-26-000032.md) | [41.9](/filings/0000860731-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,952,274 at 2026-07-27, from the cover of the [10-Q filed 2026-07-29](/filings/0000860731-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.